Reference is made to the announcement of Purapharm Corporation Limited dated 28 June 2021 in relation to the re-designation of Mr. Cheong Shin Keong ("Mr. Cheong") as a non-executive director of the Company. The board (the "Board") of directors (the "Directors") of the Company announces that with effect from 31 March 2022, Mr. Cheong retired as a non-executive Director of the Company due to expiry of his term of service under his letter of appointment as the non-executive Director of the Company. Mr. Cheong confirmed that as at the date of this announcement, (i) he does not have any claim against the Company in respect of his retirement; (ii) he does not have any disagreement with the Board; and (iii) there are no other matters in relation to his retirement that need to be brought to the attention of the shareholders of the Company and The Stock Exchange of Hong Kong Limited.